Sodium Glucose Cotransporter Inhibition in Acute Heart Failure: An In-Depth Review
Inhibitors of the sodium glucose cotransporters were initially developed for the treatment of type 2 diabetes but have since been shown to provide many benefits in heart failure, especially in heart failure with reduced ejection fraction (HFrEF). Already an established and foundational therapy for H...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2025-04-01
|
| Серія: | CJC Open |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2589790X2400653X |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|